Search - tctmd.com

Displaying 341 - 360 of 393

Sort: Relevancy | Date

Presentation TCT 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presenter: Klaus Bonaventura, Steffen Sonntag, Franz Xaver Kleber

January 03, 2012

Presentation TCT 2012

Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of Neointimal Distribution by Optical Coherence Tomography

Presenter: Hiromasa Otake, Toshiro Shinke, Junya Shite, Masayuki Nakagawa, Ryoji Nagoshi, Tsuyoshi Osue, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Presenter: Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Reo Anai, Fumihiko Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji

January 03, 2012

Presentation TCT 2012

Gender-specific outcomes after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease: a sub-analysis of Japan TAXUS Express2 post-marketing...

Presenter: Hiroyuki Okura, Jun-ichi Kotani, Ken Kozuma, Masato Nakamura

January 03, 2012

Presentation TCT 2012

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Presenter: Hiromasa Otake, Junya Shite, Toshiro Shinke, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Comparison of Optical Coherence Tomography and Histopathology Findings Following Paclitaxel-Coating Balloon in Porcine In-stent Stenosis Model

Presenter: Arihiro Sumida, Alexander Nikanorov, Toshiro Shinke, Jinsheng Li, Jaipal Singh, Spencer King, Nicolas Chronos, Dongming Hou

January 03, 2012

Presentation TCT 2012

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

Presenter: Jose M. De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco

January 03, 2012

Presentation TCT 2012

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

Presenter: Gunnar Tepe

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

October 05, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

Advertisement

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of Neointimal Distribution by Optical Coherence Tomography

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Gender-specific outcomes after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease: a sub-analysis of Japan TAXUS Express2 post-marketing...

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Comparison of Optical Coherence Tomography and Histopathology Findings Following Paclitaxel-Coating Balloon in Porcine In-stent Stenosis Model

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated Versus Paccocath Paclitaxel Coated Balloons.

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

DES Associated with Less Downstream Lesion Development than BMS

First DES for Above-the-Knee Vascular Disease on the Horizon

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

Clinical Variables Added to Syntax Score Increases Predictive Ability

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content